AN2 Therapeutics
ANTX
ANTX
31 hedge funds and large institutions have $14.5M invested in AN2 Therapeutics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
65% less capital invested
Capital invested by funds: $41.7M → $14.5M (-$27.3M)
Holders
31
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.15M | |
| 2 | +$477K | |
| 3 | +$438K | |
| 4 |
AC
Aldebaran Capital
Carmel,
Indiana
|
+$108K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$99.2K |
Top Sellers
| 1 | -$6.92M | |
| 2 | -$4.49M | |
| 3 | -$3.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.34M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$2.61M |